Your browser doesn't support javascript.
loading
Effectiveness of Palonosetron, 1-Day Dexamethasone, and Aprepitant in Patients Undergoing Carboplatin-Based Chemotherapy.
Hayashi, Toshinobu; Shimokawa, Mototsugu; Matsuo, Koichi; Uchiyama, Masanobu; Kawada, Kei; Nakano, Takafumi; Egawa, Takashi.
Afiliação
  • Hayashi T; Department of Comprehensive Pharmaceutical Care, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan.
  • Shimokawa M; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
  • Matsuo K; Department of Comprehensive Pharmaceutical Care, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan.
  • Uchiyama M; Department of Pharmacy, Fukuoka University Hospital, Fukuoka, Japan.
  • Kawada K; Department of Pharmacy, Kochi Medical School Hospital City, Nankoku, Japan.
  • Nakano T; Department of Comprehensive Pharmaceutical Care, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan.
  • Egawa T; Department of Comprehensive Pharmaceutical Care, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan.
Oncology ; 101(9): 584-590, 2023.
Article em En | MEDLINE | ID: mdl-37276851
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Antieméticos / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: Oncology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Antieméticos / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: Oncology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão